Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

162.89
+1.040.64%
Post-market: 165.312.42+1.48%16:51 EDT
Volume:3.65M
Turnover:595.00M
Market Cap:252.64B
PE:24.38
High:165.42
Open:164.21
Low:162.02
Close:161.85
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.21
T/O Rate:0.24%
Dividend:3.17
Dividend Rate:1.95%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.02
PE(LYR):24.91

Loading ...

AstraZeneca Says Tozorakimab Cuts COPD Exacerbations in Phase 3 Trials

MT Newswires Live
·
Sep 08

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live
·
Sep 08

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 08

AstraZeneca's Etcamah Opens New Breast-Cancer Treatment Paradigm

Dow Jones
·
Sep 07

J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 07

Jefferies Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 07

AstraZeneca Scores Minor Positive with U.S. Approval for Breast-Cancer Drug

Dow Jones
·
Sep 07

Citi Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 07

AstraZeneca Gets FDA Approval for Breast Cancer Treatment

Dow Jones
·
Sep 05

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

AstraZeneca's New Lung Treatment Could Become Market Leader

Dow Jones
·
Sep 03

Berenberg Bank Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 03

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

Deutsche Bank Sticks to Its Sell Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

AstraZeneca completes global license agreement for Zegfrovy in lung cancer

TIPRANKS
·
Sep 01

AstraZeneca Reports 'Meaningful Improvement' in Phase 3 Study of Lung Cancer Patients

MT Newswires Live
·
Sep 01

AstraZeneca Says Breast Cancer Combo Approved in EU; Completes Acquisition of License for Lung Cancer Treatment

MT Newswires Live
·
Sep 01

Movement Alert|AstraZeneca PLC Declines 4.14% Overnight, Competitive Threat From Summit Ivosdenib Data Weighs on Immuno-Oncology Outlook

Market Focus
·
Sep 01